sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Medical Devices

Continuous Glucose Monitoring MarketSize, Share & Industry Analysis, 2026-2034By ComponentBy Product TypeBy Sensor Wear DurationBy Sensing TechnologyBy ApplicationBy Age GroupBy Connectivity and IntegrationBy End UserBy Distribution ChannelBy Reimbursement Status

Full title & scope — all 10 axes with their segments

Continuous Glucose Monitoring Market Size, Share & Industry Analysis, By Component (Sensors, Transmitters, Receivers and Readers, Software and Data Platforms, Insertion and Accessories), By Product Type (Real-Time CGM, Intermittently Scanned CGM, Professional CGM, Over-the-Counter CGM), By Sensor Wear Duration (Up to 7 Days, 8 to 10 Days, 11 to 15 Days, Beyond 15 Days), By Sensing Technology (Minimally Invasive Enzymatic Electrochemical, Implantable Fluorescence-Based, Non-Invasive, Microneedle-Based), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes and Metabolic Health, Hospital Glycemic Management), By Age Group (Pediatric, Adult, Geriatric), By Connectivity and Integration (Standalone CGM, Integrated with Insulin Pumps, Integrated with Smart Pens, Open-Source and Third-Party Integrated), By End User (Home Care Settings, Hospitals, Clinics and Endocrinology Centers, Ambulatory Surgical and Long-Term Care Facilities, Research and Clinical Trial Organizations), By Distribution Channel (Retail Pharmacies, Online Pharmacies and E-Commerce, Direct-to-Consumer / Manufacturer Direct, Durable Medical Equipment Suppliers, Hospital Pharmacies), By Reimbursement Status (Public Insurance Reimbursed, Private Insurance Reimbursed, Out-of-Pocket), and Regional Forecast, 2026-2034

Last Updated: Nov 6, 2026Format: PDFReport ID: CDI-248862
Analyst Support

Talk to the analyst who built the estimates, and shape the scope around your question.

Complimentary Analyst Access

Every report purchase includes direct access to the lead analyst for scoping questions on the data, at no extra cost and with no separate booking process.

Custom Data Cuts

Request a tailored breakdown by geography, segment, or competitor set beyond what's in the standard report.

Speak to an Analyst
Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Continuous Glucose Monitoring Market projected to reach?

USD 36 USD Billion by 2034, CAGR 11.47%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 45% of global revenue through 2034.

05Which segment leads the market?

Sensors is the largest line by Component, at 52% of revenue in 2025.

06Who are the key companies profiled?

Dexcom, Inc., Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd, Senseonics Holdings, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Ascensia Diabetes Care Holdings AG, LifeScan, Inc., Sinocare Inc., Medtrum Technologies Inc., Roche Diabetes Care GmbH, i-SENS, Inc., Glucotrack, Inc., Biolinq, Inc., Embecta Corp., Terumo Corporation, Yuwell Medical (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Microtech Medical (Hangzhou) Co., Ltd., Ypsomed Holding AG, Diabeloop SA, Trividia Health, Inc., Nemaura Medical Inc., Dexcom Europe / Eversense partner Ascensia, Meiqi / Shenzhen Silicon Biotech Co., Ltd., Glucomen / A. Menarini Diagnostics S.r.l., Sibionics (Shenzhen Sibionics Technology Co., Ltd.). Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.